[Federal Register Volume 61, Number 179 (Friday, September 13, 1996)]
[Notices]
[Page 48495]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-23423]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to Section 19(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
National Institute of Allergy and Infectious Diseases Special Emphasis 
Panel (SEP) meeting:

    Name of SEP: Preclinical Evaluation of Therapies of 
Mycobacterium Avium Infection (Telephone Conference Call).
    Date: September 10, 1996.
    Time: 11:00 a.m.
    Place: Teleconference, 6003 Executive Boulevard, Solar Bldg., 
Rm. 4C04, Bethesda, MD 20892-7610, (301) 496-8206.
    Contact Person: Dr. Vassil Georgiev, Scientific Review Adm., 
6003 Executive Boulevard, Solar Bldg., Room 4C04, Bethesda, MD 
20892-7610.
    Purpose/Agenda: To evaluate contract proposals.
    The meeting will be closed in accordance with the provisions set 
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.
    This notice is being published less than 15 days prior to the 
above meeting due to the urgent need to meet timing limitations 
imposed by the review and funding cycle.

(Catalog of Federal Domestic Assistance Program Nos. 93.855, 
Immunology, Allergic and Immunologic Diseases Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health)

    Dated: September 6, 1996.
Margery G. Grubb,
Senior Committee Management Specialist, NIH.
[FR Doc. 96-23423 Filed 9-12-96; 8:45 am]
BILLING CODE 4140-01-M